“…It has been reported that up to 20% of patients experienced musculoskeletal pain and arthralgias during therapy 9 . Usually mild, the symptoms may disappear even if the treatment is continued 10 and, notably, the more rare, severe symptoms also tend to quickly improve after cessation of treatment 11 . The five previous reported cases of premature epiphyseal closure secondary to vitamin A therapy have all been with long‐term isotretinoin treatment (5–6 years), or with very high doses (up to 3.5 mg/kg per day), and have occurred in various joints (two knees, one elbow, one ankle, and the fifth case was an occurrence in multiple joints) 5 .…”